A Novel Bispecific Tetravalent Antibody Fusion Protein to Target Costimulatory Activity for T-cell Activation to Tumor Cells Overexpressing ErbB2/HER2
- 11 March 2005
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 346 (5), 1299-1311
- https://doi.org/10.1016/j.jmb.2004.12.052
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Successful Induction of Tumor‐specific Cytotoxic T Lymphocytes from Patients with Non‐small Cell Lung Cancer Using CD80‐transfected Autologous Tumor CellsJapanese Journal of Cancer Research, 2001
- Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponseGene Therapy, 2000
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- High Concentrations of Antigenic Ligand Activate and Do Not Tolerize Naive CD4 T Cells in the Absence of CD28/B7 CostimulationCellular Immunology, 1997
- Control of T lymphocyte signal transduction through clonal anergyJournal of Molecular Medicine, 1996
- Triggering of Natural Killer Cells by the Costimulatory Molecule CD80 (B7-1)Immunity, 1996
- The Complexities of T‐Cell Co‐stimulation: CD28 and BeyondImmunological Reviews, 1996
- T Cell Activation Determined by T Cell Receptor Number and Tunable ThresholdsScience, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993